Gharibkandi, N.A.; Majkowska-Pilip, A.; Walczak, R.; Wierzbicki, M.; Bilewicz, A.
Au@109Pd Core–Shell Nanoparticles Conjugated to Panitumumab for the Combined β−—Auger Electron Therapy of Triple-Negative Breast Cancer. Int. J. Mol. Sci. 2024, 25, 13555.
https://doi.org/10.3390/ijms252413555
AMA Style
Gharibkandi NA, Majkowska-Pilip A, Walczak R, Wierzbicki M, Bilewicz A.
Au@109Pd Core–Shell Nanoparticles Conjugated to Panitumumab for the Combined β−—Auger Electron Therapy of Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2024; 25(24):13555.
https://doi.org/10.3390/ijms252413555
Chicago/Turabian Style
Gharibkandi, Nasrin Abbasi, Agnieszka Majkowska-Pilip, Rafał Walczak, Mateusz Wierzbicki, and Aleksander Bilewicz.
2024. "Au@109Pd Core–Shell Nanoparticles Conjugated to Panitumumab for the Combined β−—Auger Electron Therapy of Triple-Negative Breast Cancer" International Journal of Molecular Sciences 25, no. 24: 13555.
https://doi.org/10.3390/ijms252413555
APA Style
Gharibkandi, N. A., Majkowska-Pilip, A., Walczak, R., Wierzbicki, M., & Bilewicz, A.
(2024). Au@109Pd Core–Shell Nanoparticles Conjugated to Panitumumab for the Combined β−—Auger Electron Therapy of Triple-Negative Breast Cancer. International Journal of Molecular Sciences, 25(24), 13555.
https://doi.org/10.3390/ijms252413555
